GLP-1 drugs reduce appetite, making weight loss feel easier
Second-line treatments include basal insulin, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1RA), sodiumglucose cotransporter 2 inhibitors (SGLT2-I), sulfonylureas (SU), or thiazolidinediones (TZD)
Which Weight Loss Surgeries Are Covered
The study reported that the CoEQ was used on an item-by-item basis in previous pharmaceutical weight loss trials
The hepatic steatosis of each section was observed by optical microscope using a model BX53 instrument (Olympus, Tokyo, Japan)
Paired with periodic metabolic monitoring, this is how you lock in results permanently instead of cycling back to where you started